Virtu Financial
VIRT NYSE Investment Banking & Brokerage Financials FY2016βFY2025
Virtu Financial's revenue rose 26.2% to $3.6 billion in fiscal 2025. Its net margin was 12.9%, up from 9.6% a year earlier. Free cash flow was $496 million, down 15.5%. It paid out $2 million in dividends and buybacks, 0% of free cash flow. The diluted share count fell 2.9%.
What Virtu Financial does
No business description yet.
- Legal name
- Virtu Financial, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001592386-26-000009
0001592386
Revenue and margins
Virtu Financial had $3.6B of revenue in fiscal 2025, up 26.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 22.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $496M in fiscal 2025, 13.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Virtu Financial returned $1.6M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count fell 2.9%.
Value Virtu Financial yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.0B and divides by 85.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 9.3x Β· peers 25.4x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Virtu Financial can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.1B | $982M | $820M | $873M | $1.1B |
| Debt incl. finance leases | $1.7B | $1.8B | $1.8B | $1.8B | $2.1B |
| Net debt / EBITDA | 0.5x | 1.1x | 1.8x | 1.1x | 0.8x |
| Debt / equity | 1.1x | 1.4x | 1.5x | 1.4x | 1.3x |
| Interest coverage | 13.5x | 7.1x | 4.3x | 7.6x | 9.2x |
| Total assets | $10.3B | $10.6B | $14.5B | $15.4B | $20.2B |
| Total liabilities | $8.5B | $8.9B | $13.1B | $13.9B | $18.2B |
| Shareholders' equity | $1.5B | $1.3B | $1.2B | $1.3B | $1.6B |
| Net debt (β = net cash) | $602M | $834M | $936M | $930M | $1.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β2.8% | β2.2% | β0.3% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Virtu Financial VIRT | $4.9B | 26.3% | β | 13.6% | 37.9% | 9.3x | β | |
| Evercore EVR | $10.4B | 29.5% | β | 30.5% | β | 14.2x | 5 | Compare β |
| Robinhood HOOD | $86.7B | 51.6% | β | 36.3% | β | 41.9x | β | Compare β |
| BGC Group BGC | $5.6B | 30.0% | β | 12.7% | 13.2% | 28.8x | β | Compare β |
| Houlihan Lokey HLI | $8.9B | 9.6% | 20.1% | 26.1% | β | 22.0x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $702M | $1.0B | $1.9B | $1.5B | $3.2B | $2.8B | $2.4B | $2.3B | $2.9B | $3.6B |
| Interest expense | $28.3M | $64.1M | $71.8M | $122M | $87.7M | $80.0M | $92.0M | $99.3M | $97.8M | $133M |
| Pretax income | $180M | $113M | $696M | β$116M | $1.4B | $997M | $557M | $325M | $645M | $1.1B |
| Income tax | $21.3M | $94.3M | $76.2M | β$12.3M | $262M | $170M | $88.5M | $61.2M | $110M | $182M |
| Net income | $33.0M | $2.9M | $289M | β$58.6M | $649M | $477M | $265M | $142M | $276M | $468M |
| Diluted EPS | $0.83 | $0.03 | $2.78 | β$0.53 | $5.16 | $3.91 | $2.44 | $1.42 | $2.97 | $5.13 |
| Diluted shares | 0.04B | 0.06B | 0.10B | 0.11B | 0.12B | 0.12B | 0.10B | 0.09B | 0.09B | 0.09B |
| Cash flow | ||||||||||
| Cash from operations | $240M | $291M | $715M | $169M | $1.1B | $1.2B | $707M | $492M | $599M | $518M |
| Capital expenditure | $11.9M | $18.9M | $26.5M | $9.3M | $28.9M | $24.6M | $27.2M | $37.8M | $12.4M | $22.8M |
| Free cash flow | $228M | $272M | $688M | $159M | $1.0B | $1.1B | $680M | $454M | $587M | $496M |
| Depreciation and amortization | $19.8M | $52.2M | $74.5M | $115M | $112M | $98.1M | $90.9M | $89.6M | $75.0M | $66.8M |
| Stock-based compensation | $22.9M | $26.3M | $31.9M | $71.7M | $59.8M | $55.8M | $67.2M | $63.9M | $75.5M | $100M |
| Acquisitions | $0.0M | $5.6M | $0.0M | $836M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $4.5M | $2.7M | $66.2M | $0.2M | $0.0M | $3.5M | $8.3M | $1.6M | $0.0M | $1.6M |
| Dividends paid | $37.8M | $63.8M | $100M | $112M | $121M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $42.3M | $66.5M | $167M | $113M | $121M | $3.5M | $8.3M | $1.6M | $0.0M | $1.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $181M | $533M | $730M | $732M | $890M | $1.1B | $982M | $820M | $873M | $1.1B |
| Total debt | $590M | $1.4B | $922M | $2.0B | $1.7B | $1.7B | $1.8B | $1.7B | $1.8B | $2.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $13.4M | $11.7M | $6.6M | $15.3M | $29.6M | $23.1M | $20.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $29.7M | $137M | $113M | $116M | $114M | $89.6M | $85.2M | $100M | $91.4M | $96.4M |
| Total assets | $3.7B | $7.3B | $7.4B | $9.6B | $10.0B | $10.3B | $10.6B | $14.5B | $15.4B | $20.2B |
| Total liabilities | $3.2B | $6.2B | $5.9B | $8.4B | $8.1B | $8.5B | $8.9B | $13.1B | $13.9B | $18.2B |
| Shareholders' equity | $146M | $831M | $1.1B | $931M | $1.5B | $1.5B | $1.3B | $1.2B | $1.3B | $1.6B |
| Margins | ||||||||||
| EBITDA margin | 32.4% | 22.3% | 44.9% | 8.0% | 48.8% | 41.8% | 31.3% | 22.4% | 28.4% | 35.6% |
| Net margin | 4.7% | 0.3% | 15.4% | β3.9% | 20.0% | 17.0% | 11.2% | 6.2% | 9.6% | 12.9% |
| FCF margin | 32.4% | 26.4% | 36.6% | 10.5% | 31.9% | 40.8% | 28.7% | 19.8% | 20.4% | 13.6% |
| Returns | ||||||||||
| Return on capital | 19.5% | 6.0% | 36.8% | 0.2% | 46.0% | 34.7% | 22.1% | 14.3% | 25.9% | 37.9% |
| Return on equity | β | 0.6% | 30.8% | β5.9% | 54.1% | 31.6% | 18.3% | 11.2% | 22.5% | 33.0% |
| Return on assets | 0.9% | 0.1% | 3.9% | β0.7% | 6.6% | 4.7% | 2.5% | 1.1% | 1.9% | 2.6% |
| Growth | ||||||||||
| Revenue growth | β11.8% | 46.4% | 82.8% | β19.2% | 113.5% | β13.2% | β15.9% | β3.0% | 25.5% | 26.3% |
| Net income growth | 57.9% | β91.1% | 9,748.3% | β120.2% | β | β26.5% | β44.4% | β46.4% | 94.6% | 69.4% |
| EPS growth | 40.7% | β96.4% | 9,166.7% | β119.1% | β | β24.2% | β37.6% | β41.8% | 109.2% | 72.7% |
| FCF growth | β6.7% | 19.3% | 153.3% | β76.8% | 547.2% | 11.2% | β40.8% | β33.2% | 29.2% | β15.5% |
| Share count change | 9.1% | 62.4% | 63.1% | 11.6% | 7.4% | β3.2% | β11.8% | β9.9% | β6.7% | β2.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.8x | 3.9x | 0.2x | 10.5x | 0.5x | 0.5x | 1.1x | 1.8x | 1.1x | 0.8x |
| Debt / equity | β | 1.7x | 0.9x | 2.2x | 1.2x | 1.1x | 1.4x | 1.5x | 1.4x | 1.3x |
| Interest coverage | 7.3x | 2.8x | 10.7x | 0.1x | 16.8x | 13.5x | 7.1x | 4.3x | 7.6x | 9.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 1.8% | 1.4% | 0.6% | 0.9% | 0.9% | 1.2% | 1.7% | 0.4% | 0.6% |
| Stock comp / revenue | 3.3% | 2.6% | 1.7% | 4.7% | 1.9% | 2.0% | 2.8% | 2.8% | 2.6% | 2.8% |
| Payouts / FCF | 18.6% | 24.5% | 24.2% | 70.6% | 11.7% | 0.3% | 1.2% | 0.3% | 0.0% | 0.3% |
| Quality scores | ||||||||||
| Accruals ratio | β5.8% | β5.2% | β5.8% | β2.7% | β4.2% | β6.9% | β4.2% | β2.8% | β2.2% | β0.3% |
Source: SEC EDGAR XBRL filings (CIK 0001592386). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.